The role of positron emission tomography imaging in movement disorders (Q35692956)

9 August 2017

1 reference

title

The role of positron emission tomography imaging in movement disorders (English)

1 reference

positron emission tomography

9 August 2017

main subject

1 reference

1

Nicolaas I Bohnen

1 reference

9 August 2017

Kirk A Frey

2

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Neuroimaging clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

13

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

791-803

1 reference

Imaging basal ganglia function

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

A clinicopathologic study of 100 cases of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

18 FFluoro-dopa, an analogue of dopa, and its use in direct external measurements of storage, degradation, and turnover of intracerebral dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

PET and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

The metabolic anatomy of tremor in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Fortnightly Review: Parkinsonism--recognition and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Voxel-based distribution of metabolic impairment in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Huntington's disease progression. PET and clinical observations.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Decreased striatal monoaminergic terminals in Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

High presynaptic dopaminergic activity in children with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Pure hemidystonia with basal ganglion abnormalities on positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Diminished regional cerebral blood flow response to vibration in patients with blepharospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Deficient activation of the motor cortical network in patients with writer's cramp

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Functional brain networks in DYT1 dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Globus pallidus deep brain stimulation for generalized dystonia: clinical and PET investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Parkinson's disease and essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Significance of parkinsonian manifestations in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

123I-IPT brain SPECT study in essential tremor and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Glucose metabolism in the brain of patients with essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

Preliminary report: activation of the cerebellum in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

A positron emission tomography study of cerebral activation associated with essential and writing tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900096-0

7 January 2021

10.1016/S1052-5149(03)00096-0

Identifiers

DOI

1 reference

9 August 2017

1 reference